Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-14-059634

10% owner bought 325,000 shares at $15.00 ($4,875,000)

  • 10% owner acquired 4,319,328 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Novartis Bioventures Ltd 10% owner 2014-09-22 Conversion +4,319,328 4,319,328 D: show line 1 in the form
Novartis Bioventures Ltd 10% owner 2014-09-22 Purchase +325,000 $15.00 $4,875,000 4,644,328 D: show line 2 in the form
Open-market purchases · 325,000 sh · avg $15.00 · $4,875,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Novartis Bioventures Ltd 10% owner 2014-09-22 Conversion · Series D-1 Preferred Stock −15,396,431 0 D: show line 3 in the form
Novartis Bioventures Ltd 10% owner 2014-09-22 Conversion · Series D-2 Preferred Stock −1,539,643 0 D: show line 4 in the form
Novartis Bioventures Ltd 10% owner 2014-09-22 Conversion · Series D-3 Preferred Stock −13,222,826 0 D: show line 5 in the form
Novartis Bioventures Ltd 10% owner 2014-09-22 Conversion · Series E Preferred Stock −15,064,469 0 D: show line 6 in the form
Loading xslF345X03/doc4.xml…